Exactly. It's very similar to how content companies try to control the release of content and pricing around the world (region codes ugh). If any pharm company sells drug A in the US for $100 and sells the same drug in Africa for $1 then it's an obvious arbitration opportunity. They are trying to prevent the 'flat world' from eating sales by simply pricing it the same everywhere.